Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 345

Facebook likes Fayteq

Fayteq, a real-time video editing technology developer spun out of TU Ilmenau, has been acquired by Facebook for an undisclosed sum.

Aug 15, 2017

Unomy goes to WeWork

WeWork has paid an undisclosed amount to acquire sales and marketing intelligence software provider Unomy, allowing Leta Capital to exit.

Aug 14, 2017

Wantedly wanders toward public markets

The CyberAgent and Nihon Keizai Shimbun-backed recruitment and networking platform developer is set to float in its home country of Japan next month.

Aug 14, 2017

Walmart enters talks to pick up Birchbox

Birchbox, the beauty product subscription service that has raised $87m in financing from backers such as Comcast, has reportedly begun talks with retailers including Walmart over an acquisition.

Aug 11, 2017

Iheima hits public markets

Iheima has raised $27.3m in its initial public offering, becoming the first incubator to float in China and providing an exit to corporate investors Toread and Youyou.

Aug 10, 2017

Disney dives further into BamTech with $1.58bn

Walt Disney Company has followed its $1bn investment in online streaming technology provider BamTech by upping its stake to 75% as it prepares to launch its own streaming service.

Aug 10, 2017

Nielsen tracks down vBrand for acquisition

Nielsen has bought Nielsen Innovate graduate vBrand and will integrate the company's sport sponsorship tracking technology into its sports media offering.

Aug 7, 2017

Big Deal: Bristol-Myers Squibb tunes into IFM

The pharmaceutical company's acquisition of Novartis-backed IFM Therapeutics, consisting of $300m upfront and up to $2bn in milestone payments, is its fourth purchase of a CVC-backed company in under four years.

Aug 7, 2017

Intelesens connects to Ultralinq

Ultralinq has acquired Intelesens, a wearable device manufacturer spun out from Ulster University in 2001.

Aug 4, 2017

Clementia cleaves $120m from IPO

UCB Pharma scored an exit after the bone disease therapy developer floated at the top of its range, having secured $92.5m in funding over the past two years.

Aug 3, 2017
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here